DaVita Inc.
DVA
Rang in aandelen
#1798
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Aandeelprijs
$186.81
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$11.92B
Verandering (1 dag)
-1.10%
Verandering (1 jaar)
48.40%
Land
US
Handel DaVita Inc. (DVA)
Categorie
Healthcare
Operationele marge voor DaVita Inc. (DVA)
Operationele marge op October 2026 TTM: 15.06%
Volgens de meest recente financiële rapporten en aandelenkoers van DaVita Inc. is de huidige operationele marge (TTM) 15.06%. Eind 2024 had het bedrijf een operationele marge van 16.31%.
Geschiedenis van de operationele marge van DaVita Inc. van 2000 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 15.06% | 4.95% |
| 2025 | 14.35% | -12.02% |
| 2024 | 16.31% | 23.56% |
| 2023 | 13.20% | 14.48% |
| 2022 | 11.53% | -25.47% |
| 2021 | 15.47% | 5.45% |
| 2020 | 14.67% | 1.66% |
| 2019 | 14.43% | 7.85% |
| 2018 | 13.38% | -19.74% |
| 2017 | 16.67% | 21.06% |
| 2016 | 13.77% | 66.91% |
| 2015 | 8.25% | -41.86% |
| 2014 | 14.19% | 7.66% |
| 2013 | 13.18% | -16.79% |
| 2012 | 15.84% | -6.82% |
| 2011 | 17.00% | 10.32% |
| 2010 | 15.41% | 0.13% |
| 2009 | 15.39% | 0.26% |
| 2008 | 15.35% | -6.29% |
| 2007 | 16.38% | 8.12% |
| 2006 | 15.15% | -3.19% |
| 2005 | 15.65% | -5.61% |
| 2004 | 16.58% | -5.74% |
| 2003 | 17.59% | -15.02% |
| 2002 | 20.70% | 9.93% |
| 2001 | 18.83% | 56.14% |
| 2000 | 12.06% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 15.48% | -98.97% |
US
|
|
| 0.00% | - |
DE
|
|
| 16.80% | -98.88% |
US
|
|
| 18.67% | -98.76% |
SA
|
|
| 0.00% | - |
MY
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.